TIMP-1 protein levels in both tissues and blood have been repeatedly associated with a poor prognosis in lung cancers, but its role has been unknown. Now, a study led by Jordi Alcaraz, lecturer at the Faculty of Medicine ...
Sep 12, 2022
0
24
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of neoadjuvant immunotherapy in patients with kidney cancer. Patients with high-risk renal ...
Sep 8, 2022
0
16
A novel imaging technique significantly improves the accuracy of the diagnosis of basal cell carcinoma (BCC)—the most frequent skin cancer—compared to clinical and dermoscopic examinations alone, according to new research ...
Sep 7, 2022
0
4
The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 in BMC Cancer.
Sep 1, 2022
0
7
A Wilmot Cancer Institute scientist discovered how gene mutations fuel the growth of bile duct cancer, a rare but aggressive type of liver cancer that has been on the rise in the U.S.
Sep 1, 2022
0
6
Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Hebrew University in Jerusalem have identified in mice the cell of origin of combined liver/biliary duct carcinomas, a rare ...
Aug 19, 2022
0
46
Kinase activity is frequently altered in renal cell carcinoma (RCC), and tyrosine kinase inhibitors (TKIs) are part of the standard treatment strategy in patients with metastatic disease. However, there are still no established ...
Aug 17, 2022
0
15
A hormone secreted by fat cells can restrain the growth of liver tumors in mice, according to a new study from the University of Michigan Life Sciences Institute.
Aug 15, 2022
0
71
A new research paper was published in Oncotarget on August 3, 2022, entitled, "Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma."
Aug 11, 2022
0
2
An international group of researchers investigated why mutations often associated with renal cancer result specifically in renal cancer, instead of other cancer types.
Aug 9, 2022
0
85
